Impact of Chlorella pyrenoidosa on the attenuation of hyperglycemia-mediated oxidative stress and protection of kidney tissue in streptozotocin-cadmium induced diabetic nephropathic rats

Biomedicine and Preventive Nutrition

Volumn 2, Issue 2, 2012, Pages 125-131

  Senthilkumar, Thulasingam ^a   Ashokkumar, Natarajan ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Chlorella pyrenoidosa; Diabetic nephropathy; Oxidative stress

Indexed keywords

ALBUMIN; CREATININE; GLUCOSE; HERBACEOUS AGENT; INSULIN; STREPTOZOCIN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLORELLA; CHLORELLA PYRENOIDOSA; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; INSULIN BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; UREA BLOOD LEVEL;

ALGAE; CHLORELLA PYRENOIDOSA; RATTUS;

EID: 84861818905     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2012.01.006     Document Type: Article

References (39)

1. Geneau R., Stuckler D., Stachenko S., McKee M., Ebrahim S., Basu S., et al. Raising the priority of preventing chronic diseases: a political process. Lancet 2010, 376:1689-1698.
2. Wu A.Y., Kong N.C., de Leon F.A., Pan C.Y., Tai T.Y., Yeung V.T., et al. An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study. Diabetologia 2005, 48:17-26.
3. Edwards J.R., Prozialeck W.C. Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 2009, 238:289-293.
4. Chen L., Lei L., Jin T., Nordberg M., Nordberg G.F. Plasma metallothionein antibody, urinary cadmium, and renal dysfunction in a Chinese type 2 diabetic population. Diabetes Care 2006, 29:2682-2687.
5. Yen T.H., Lin J.L., Lin-Tan D.T., Hsu C.W., Chen K.H., Hsu H.H. Blood cadmium level's association with 18-month mortality in diabetic patients with maintenance haemodialysis. Nephrol Dial Transplant 2011, 26:998-1005.
6. Sun Z., Liu J., Zeng X., Huangfu J., Jiang Y., Wang M., et al. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Funct 2011, 2:251-258.
7. Shanmugam K.R., Mallikarjuna K., Kesireddy N., Sathyavelu Reddy K. Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats. Food Chem Toxicol 2011, 49:893-897.
8. Ramachandran S., Rajasekaran A., Kumar K.T. Antidiabetic, antihyperlipidemic and antioxidant potential of methanol extract of Tectona grandis flowers in streptozotocin induced diabetic rats. Asian Pac J Trop Med 2011, 4:624-631.
9. Merchant R.E., Andre C.A. A review of recent clinical trials of the nutritional supplement. Chlorella pyrenoidosa, for tibromyalgia, hypertension, and ulcerative colitis. J Altern Ther Health Med 2001, 7:79-91.
10. Merchant R.E., Andre C.A., Sica D.A. Nutritional supplementation with Chlorella pyrenoidosa for mild to moderate hypertension. J Med Food 2002, 5:141-152.
11. Shibata S., Natori Y., Nishihara T., Tomisaka K., Matsumoto K., Sansawa H., et al. Antioxidant and anti-cataract effects of chlorella on rats with streptozotocin-induced diabetes. J Nutr Sci Vitaminol (Tokyo) 2003, 49:334-349.
12. Guzmán S., Gato A., Lamela M., Freire-Garabal M., Calleja J.M. Anti-inflammatory and immunomodulatory activities of polysaccharide from Chlorella stigmatophora and Phaeodactylum tricornutum. Phytother Res 2003, 17:665-670.
13. Hsu H.Y., Jeyashoke N., Yeh C.H., Song Y.J., Hua K.F., Chao L.K. Immunostimulatory bioactivity of algal polysaccharides from Chlorella pyrenoidosa activates macrophages via Toll-like receptor 4. J Agric Food Chem 2010, 58:927-936.
14. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem 1969, 6:24.
15. Bürgi W., Briner M., Franken N., Kessler A.C. One-step sandwich enzyme immunoassay for insulin using monoclonal antibodies. Clin Biochem 1998, 21:311-314.
16. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
17. Kakkar P., Das B., Viswanathan P.N. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 1984, 21:130-132.
18. Sinha K.A. Colorimetric assay of catalase. Anal Biochem 1972, 47:389-394.
19. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G., et al. Biochemical roles as a component of glutathione peroxidase. Science 1984, 179:588-590.
20. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
21. Natelson S., Scott M.L., Beffa C. A rapid method for the estimation of urea in biologic fluids. Am J Clin Pathol 1951, 21:275-281.
22. Brod J., Sirota J.H. The renal clearance of endogenous " creatinine" in man. J Clin Invest 1948, 27:645-654.
23. Balakumar P., Chakkarwar V.A., Krishan P., Singh M. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?. Biomed Pharmacother 2009, 63:171-179.
24. Louro T.M., Matafome P.N., Nunes E.C., da Cunha F.X., Seiça R.M. Insulin and metformin may prevent renal injury in young type 2 diabetic Goto-Kakizaki rats. Eur J Pharmacol 2011, 653:89-94.
25. Wautier J.L., Guillausseau P.J. Advanced glycation end products, their receptors and diabetic angiopathy. Diabetes Metab 2001, 27:535-542.
26. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia 2008, 51:216-226.
27. Cherng J.Y., Shih M.F. Improving glycogenesis in streptozocin (STZ) diabetic mice after administration of green algae Chlorella. Life Sci 2006, 78:1181-1186.
28. Jong-Yuh C., Mei-Fen S. Potential hypoglycemic effects of Chlorella in streptozotocin-induced diabetic mice. Life Sci 2005, 77:980-990.
29. Jeong H., Kwon H.J., Kim M.K. Hypoglycemic effect of Chlorella vulgaris intake in type 2 diabetic Goto-Kakizaki and normal Wistar rats. Nutr Res Pract 2009, 3:23-30.
30. Rodrigo R., Rivera G. Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med 2002, 33:409-422.
31. Baliga R., Ueda N., Walker P.D., Shah S.V. Oxidant mechanisms in toxic acute renal failure. Drug Metab Rev 1999, 31:971-997.
32. Shimeda Y., Hirotani Y., Akimoto Y., Shindou K., Ijiri Y., Nishihori T., et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biol Pharm Bull 2005, 28:1635-1638.
33. Jayaraman J., Veerappan M., Namasivayam N. Potential beneficial effect of naringenin on lipid peroxidation and antioxidant status in rats with ethanol-induced hepatotoxicity. J Pharm Pharmacol 2009, 61:1383-1390.
34. Geetha G., Kalavalarasariel Gopinathapillai P., Sankar V. Anti diabetic effect of Achyranthes rubrofusca leaf extracts on alloxan induced diabetic rats. Pak J Pharm Sci 2011, 24:193-199.
35. Rodrigo R., Bosco C. Oxidative stress and protective effects of polyphenols: comparative studies in human and rodent kidney. A review. Comp Biochem Physiol C Toxicol Pharmacol 2006, 142:317-327.
36. Inbaraj B.S., Chien J.T., Chen B.H. Improved high performance liquid chromatographic method for determination of carotenoids in the microalga Chlorella pyrenoidosa. J Chromatogr A 2006, 1102:193-199.
37. Almdal T.P., Vilstrup H. Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetologia 1988, 31:114-118.
38. Sivakumar S., Palsamy P., Subramanian S.P. Impact of D-pinitol on the attenuation of proinflammatory cytokines, hyperglycemia-mediated oxidative stress and protection of kidney tissue ultrastructure in streptozotocin-induced diabetic rats. Chem Biol Interact 2010, 188:237-245.
39. Yamabe N., Yokozawa T., Oya T., Kim M. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther 2006, 319:228-236.